Target intelligence / Profile preview

Guanine nucleotide exchange factor subunit RIC1 (RIC1)

Target
RIC1
Molecular classification
Enzyme (Guanine nucleotide exchange factor, specifically for Rab GTPases), Rab GEF complex subunit, Interacts with arrestin domain proteins
01

Overview

Guanine nucleotide exchange factor subunit RIC1 (RIC1) is a subunit of the Ric1-Rgp1 complex, a conserved guanine nucleotide exchange factor that activates Rab6A through catalyzing the exchange of GDP for GTP, thereby regulating membrane trafficking and organelle homeostasis, particularly at the Golgi apparatus[1][2][4]. The Ric1 protein contains two β-propeller domains and a C-terminal α-solenoid domain that interfaces with the nucleotide-binding site of Rab6, while the Rgp1 subunit has an arrestin fold that interacts with the unstructured hypervariable domain of Rab6[1][2][3]. Both Ric1 and Rgp1 are essential for Rab6 activation, and their depletion disrupts retrograde transport in cells[4]. RIC1 appears to be highly conserved across eukaryotes and is implicated in the regulation of cargo sorting and Golgi function, with emerging relevance to diseases linked to trafficking defects such as cancer and neurodegenerative disorders[1][2][4]. No direct clinical drugs or biomarkers are currently associated with RIC1 as a pharmacological target.

Other names
RIC1CIP150KIAA1432bA207C16.1Connexin-43-interacting protein of 150 kDaRAB6A-GEF complex partner protein 1Protein RIC1 homologCATIFARAB6A GEF complex partner 1
02

Mechanism of action

Drugs or ligands targeting RIC1 would potentially act by modulating guanine nucleotide exchange activity on Rab6A, affecting cargo trafficking and Golgi function. No drugs currently documented act via this mechanism for RIC1[1][2][4].

03

Biological functions

Guanine nucleotide exchange for Rab6A (and possibly Rab33B)Regulation of organelle homeostasisRegulation of membrane trafficking, especially at the Golgi apparatusInvolvement in retrograde transport
04

Disease associations

Cancer (potential role via its trafficking and Golgi regulation; specific disease associations are under investigation)Neurodegenerative disease (possible, as trafficking dysfunctions often relate to neuronal disorders)Other (General cellular trafficking or membrane homeostasis abnormalities)
05

Safety considerations

Potential disruption of Golgi trafficking and organelle homeostasis if the complex is inhibited or dysregulated[1][2][4].Possible cytotoxicity due to trafficking defectsBroad involvement in membrane trafficking may lead to pleiotropic effects

Beyond the preview

Go deeper on Guanine nucleotide exchange factor subunit RIC1 (RIC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanine nucleotide exchange factor subunit RIC1 (RIC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call